Autoimmunity and Vaccines
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Hematology and Immunology".
Deadline for manuscript submissions: closed (1 September 2021) | Viewed by 641
Special Issue Editors
Interests: autoimmune diseases; clinical immunology; systemic lupus erythematosus; rheumatology
Special Issues, Collections and Topics in MDPI journals
Interests: proteomics; peptidology; immunoreactivity; immunotolerance; molecular mimicry
Special Issue Information
Dear Colleagues,
This Special Issue will discuss how infection can induce autoimmune diseases, mainly by hyperstimulation of the immune system of genetically prone people. An emphasis will be put on molecular mimicry. COVID 19 will be a case in point with 12 autoimmune diseases induced by the virus, as well as 15 divers of autoantibodies. The issue will cover the impact of vaccines with molecular mimicry and aluminum as an adjuvant, the advantage of mRNA, and who should be aware of vaccines and what to do when autoimmune diseases emerge. There will also be descriptions of how to prepare a better and more safe vaccine. Cytokine storms, mechanisms, and how to avoid them, will also be discussed.
Prof. Dr. Yehuda Shoenfeld
Dr. Darja Kanduc
Dr. Manuel Martínez-Lavín
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Autoimmunity
- Autoimmune diseases
- Autoantibodies
- Molecular mimicry
- Vaccines
- COVID 19
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
